Douglass B. Given, MD

Doug Given, MD, is a founder and is Chairman of Vivaldi Biosciences, Inc. Vivaldi develops genetically modified intranasal vaccines for epidemic and pandemic viral respiratory diseases. Vivaldi's lead vaccine in clinical development is the DeltaFLU universal influenza vaccine for nasal spray administration.

Doug is a founder of Health2047 Capital Partners, a health care venture capital firm, and has served as managing partner from 2018 to present. He founded, with the American Medical Association, Health2047 Inc., an integrated health care company formation firm, and served as its chief executive from 2015 to 2018. Doug previously spent more than two decades in venture capital as a general partner at life sciences investor Bay City Capital; he was associated with the partnership from 1999 to 2015. Beginning in 1983 he was a global corporate and operating executive at Lilly, Monsanto, Schering Plough, and Mallinckrodt. As a serial entrepreneur, in addition to a number of private companies, he led three public biopharmaceutical companies as CEO. 

Doug has served on more than 20 public and private company boards. He currently is chairman of Arrowhead Pharmaceuticals, Inc., chairman of Visirna Inc., and serves as a Director of Health2047 Inc. and BrYet Health Ltd. He is managing partner at the G5 Partners LLC family office. 

He serves in advisory roles on the University of Chicago Pritzker School of Medicine and Biological Sciences Division Council, and on the Health Advisory Board for the Bloomberg School. He has served on the Harvard School of Public Health HIV/AIDS Initiative and International Council, the Stanford Medicine Community Council, and advisory boards for the Stanford Institute for Economic Policy and Research, the Houston Methodist Research Institute, the Queensland Investment Corporation, and InnoMed Ventures. 

Doug is a physician scientist and received his MD and PhD (Virology) degrees from the University of Chicago and an MBA from the Wharton School at the University of Pennsylvania. He was a clinical and research fellow in Internal Medicine and Infectious Diseases at Massachusetts General Hospital and Harvard Medical School, and a professor and attending physician at Indiana University School of Medicine.